ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,856Medicare Part D Prescriptions Filled, Including Refills

Rank: 150 out of 2094

$704K Total Retail Price of All Prescriptions

Rank: 246 out of 2094

466 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 466 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

5% of this provider’s 466 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 8,213 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 374 335 1 2
LEVOTHYROXINE SODIUM 371 298 2 3
METFORMIN HCL 294 236 3 8
OMEPRAZOLE 288 206 4 4
ATORVASTATIN CALCIUM 267 249 5 5
SIMVASTATIN 258 234 6 1
FUROSEMIDE 221 204 7 6
DIOVAN 197 161 8 13
WARFARIN SODIUM 184 170 9 11
DONEPEZIL HCL 179 168 10 20
ZOLPIDEM TARTRATE 177 101 11 14
HYDROCHLOROTHIAZIDE 168 166 12 12
CARVEDILOL 159 137 13 19
ENDOCET 150 60 S2 14 88
METOPROLOL SUCCINATE 135 110 15 9
CIPROFLOXACIN HCL 133 106 16 81
AZITHROMYCIN 130 87 17 27
METOPROLOL TARTRATE 124 108 18 10
GLIMEPIRIDE 122 91 19 31
DIVALPROEX SODIUM 119 92 20 69
RAMIPRIL 119 94 20 48
ENALAPRIL MALEATE 112 98 22 25
RISPERIDONE 105 92 23 56
MELOXICAM 102 90 24 49
CRESTOR 101 79 25 15
CLOPIDOGREL 92 91 26 22
POTASSIUM CHLORIDE 92 75 26 24
LEVETIRACETAM 90 64 28 78
TRIAMTERENE-HCTZ 83 58 29 87
NEXIUM 82 53 30 16
QUETIAPINE FUMARATE 81 44 31 71
AMLODIPINE BESYLATE-BENAZEPRIL 80 58 32 58
NYSTATIN-TRIAMCINOLONE 78 55 33 207
FAMOTIDINE 78 66 33 34
OLANZAPINE 78 53 33 113
PRAVASTATIN SODIUM 77 69 36 18
LISINOPRIL 77 67 36 7
SERTRALINE HCL 75 60 38 26
ABILIFY 75 46 38 165
PLAVIX 74 71 40 38
ISOSORBIDE MONONITRATE ER 74 70 40 57
PROAIR HFA 72 42 42 45
ESCITALOPRAM OXALATE 71 49 43 46
CYMBALTA 69 43 44 61
PREDNISONE 69 36 44 54
AMOX TR-POTASSIUM CLAVULANATE 68 47 46 107
PAROXETINE HCL 67 60 47 77
QUINAPRIL HCL 66 65 48 123
LAMOTRIGINE 65 52 49 177
NAMENDA 64 64 50 32
LIPITOR 60 53 51 39
GABAPENTIN 60 29 51 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 60 55 51 55
PANTOPRAZOLE SODIUM 60 60 51 37
ADVAIR DISKUS 58 38 55 36
FLUTICASONE PROPIONATE 57 30 56 41
ATENOLOL 55 45 57 21
TAMSULOSIN HCL 53 43 58 29
VERAPAMIL ER 52 42 59 161
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 7, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.